Immunologic Factors

"Immunologic Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Descriptor ID	D007155
MeSH Number(s)	D27.505.696.477
Concept/Terms	Immunologic Factors Immunologic Factors Immune Factors Factors, Immune Immunological Factors Factors, Immunological Factors, Immunologic Immunomodulators Immunomodulators Biological Response Modifiers Biological Response Modifiers Biomodulators Modifiers, Biological Response Response Modifiers, Biological

Below are MeSH descriptors whose meaning is more general than "Immunologic Factors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Immunologic Factors [D27.505.696.477]

Below are MeSH descriptors whose meaning is more specific than "Immunologic Factors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunologic Factors" by people in this website by year, and whether "Immunologic Factors" was a major or minor topic of these publications.

Bar chart showing 84 publications over 21 distinct years, with a maximum of 12 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
2002	1	0	1
2004	0	1	1
2005	0	1	1
2006	0	2	2
2007	1	4	5
2008	8	4	12
2009	3	2	5
2010	5	2	7
2011	4	1	5
2012	3	0	3
2013	3	3	6
2014	2	3	5
2015	3	0	3
2016	4	4	8
2018	3	2	5
2019	3	1	4
2020	3	0	3
2021	3	1	4
2022	0	2	2
2024	0	1	1

Below are the most recent publications written about "Immunologic Factors" by people in Profiles.

Yang R, Ko YH, Li F, Lokareddy RK, Hou CD, Kim C, Klein S, Antol?nez S, Mar?n JF, P?rez-Segura C, Jarrold MF, Zlotnick A, Hadden-Perilla JA, Cingolani G. Structural basis for nuclear import of hepatitis B virus (HBV) nucleocapsid core. Sci Adv. 2024 Jan 12; 10(2):eadi7606.

View in: PubMed
Thomas S, Mercogliano G, Prendergast GC. Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment. PLoS One. 2022; 17(11):e0276910.

View in: PubMed
Nicolò E, Giugliano F, Ascione L, Tarantino P, Corti C, Tolaney SM, Cristofanilli M, Curigliano G. Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives. Cancer Treat Rev. 2022 May; 106:102395.

View in: PubMed
Shields CL, Paulose SA, Yaghy A, Dalvin LA, Constantinescu AB, Lally SE, Shields JA. Ocular Surface Squamous Neoplasia Managed With Primary Interferon a2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers. Cornea. 2021 Nov 01; 40(11):1387-1394.

View in: PubMed
Fadul CE, Mao-Draayer Y, Ryan KA, Noelle RJ, Wishart HA, Channon JY, Kasper IR, Oliver B, Mielcarz DW, Kasper LH. Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6).

View in: PubMed
Santos AH, Leghrouz MA, Bueno EP, Andreoni KA. Impact of antibody induction on the outcomes of new onset diabetes after kidney transplantation: a registry analysis. Int Urol Nephrol. 2022 Mar; 54(3):637-646.

View in: PubMed
Alecsandru D, Klimczak AM, Garcia Velasco JA, Pirtea P, Franasiak JM. Immunologic causes and thrombophilia in recurrent pregnancy loss. Fertil Steril. 2021 03; 115(3):561-566.

View in: PubMed
Roshdy WH, Rashed HA, Kandeil A, Mostafa A, Moatasim Y, Kutkat O, Abo Shama NM, Gomaa MR, El-Sayed IH, El Guindy NM, Naguib A, Kayali G, Ali MA. EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020; 15(11):e0241739.

View in: PubMed
Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD, Fuda FS, Chen W, Jaso JM. Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity. Am J Clin Pathol. 2020 11 04; 154(6):816-827.

View in: PubMed
Deaner JD, Giacometti JN. Rituximab in Ocular Adnexal Lymphoma and Orbital Inflammatory Disease. Int Ophthalmol Clin. 2020; 60(2):63-75.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement